Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Glenmark Pharmaceuticals Limited
Press Release Dec 21 2022
Business
Dec 21 2022
5 min read

Press Release Dec 21 2022

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 21, 2022, titled "Glenmark is the first company to launch in India a Triple FDC of Teneligliptin +Pioglitazone + Metformin for Adults with Type 2 Diabetes & High Insulin Resistance".

View Attachment